CG Oncology, Inc. Common stock (CGON) Earnings
CG Oncology, Inc. Common stock is expected to report next earnings on November 13, 2026 (in NaN days), with a consensus EPS estimate of $-0.86. CGON has beaten EPS estimates in 1 of its last 7 reported quarters (average surprise -17.5% over the last four).
Next earnings
Nov 13, 2026in NaN days
EPS est $-0.86 · Revenue est $547684
Track record
Beat EPS in 1 of 7 quarters
Avg surprise -17.5% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 6, 2026 | $-0.66 | $-0.90 | -35.5% | $1M | +220.7% |
| May 8, 2026 | $-0.58 | $-0.71 | -22.4% | $1M | +139.1% |
| Nov 14, 2025 | $-0.56 | $-0.57 | -2.0% | $2M | +2706.4% |
| Aug 8, 2025 | $-0.49 | $-0.54 | -10.2% | — | — |
| Mar 28, 2025 | $-0.41 | $-0.48 | -17.1% | $456000 | +267.9% |
| Aug 8, 2024 | $-0.42 | $-0.28 | +33.3% | $111000 | — |
| May 9, 2024 | $-0.35 | $-0.36 | -2.9% | $529000 | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.